Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

MannKind Corp (NASDAQ:MNKD)

1.46
Delayed Data
As of 3:59pm ET
 +0.06 / +4.29%
Today’s Change
0.67
Today|||52-Week Range
4.95
-54.14%
Year-to-Date

Today’s Trading

Previous close1.40
Today’s open1.41
Day’s range1.38 - 1.53
Volume2,357,104
Average volume (3 months)3,109,981
Market cap$146.6M
Dividend yield--
Data as of 3:59pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-168.75%
Earnings growth (next 5 years)+26.80%
Revenue growth (last year)--
P/E ratio1.0
Price/Sales1.68
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ADMPAdamis Pharmaceutica...+0.05+1.10%
RDHLRedhill Biopharma Lt...+0.21+2.39%
TRVNTrevena Inc-0.04-1.68%
REPHRecro Pharma Inc-0.05-0.68%
Data as of 3:59pm ET, 08/18/2017

Financials

Next reporting dateNovember 8, 2017
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$174.8M
Annual profit (last year)$125.7M
Net profit margin71.91%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Michael E. Castagna
Chief Financial Officer &
Chief Accounting Officer
Steven Binder
Corporate headquarters
Westlake Village, California

Forecasts